Cargando…
Reply to ‘COVID‐19 severity, miR‐21 targets, and common human genetic variation’
Autores principales: | Derda, Anselm A., Garg, Ankita, Bär, Christian, Thum, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426821/ https://www.ncbi.nlm.nih.gov/pubmed/34355474 http://dx.doi.org/10.1002/ejhf.2322 |
Ejemplares similares
-
miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome
por: Huang, Cheng-Kai, et al.
Publicado: (2020) -
miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
por: Sieweke, Jan-Thorben, et al.
Publicado: (2020) -
Circulating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease
por: Goldschmidt, Imeke, et al.
Publicado: (2016) -
MicroRNAs bei COVID-19: kleine Moleküle mit großem Potenzial?
por: Bär, Christian, et al.
Publicado: (2021) -
Evaluation of Plasma miR-21 and miR-152 as Diagnostic Biomarkers for Common Types of Human Cancers
por: Chen, Hankui, et al.
Publicado: (2016)